ReviewLeukemia & lymphoma2018
Minimal residual disease analysis in myeloma - when, why and where.
Uday Yanamandra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papercites it
ReviewLeukemia & lymphoma2018
Uday Yanamandra et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.